Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infant Malaria Vaccine Schedule Optimization
PACTR202411825510335Phase 2Unknown
- Sponsor
- PATH
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in malaria (4 cohorts), sponsored by PATH. Status: unknown.
02
Conditions
malaria
Beyond the preview
Go deeper on PACTR202411825510335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202411825510335.